PLGA Based Drug Carrier and Pharmaceutical Applications (Record no. 3001045)

MARC details
000 -LEADER
fixed length control field 05823naaaa2201537uu 4500
001 - CONTROL NUMBER
control field https://directory.doabooks.org/handle/20.500.12854/68416
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20220714181031.0
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number books978-3-0365-0221-2
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9783036502205
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9783036502212
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.3390/books978-3-0365-0221-2
Terms of availability doi
041 0# - LANGUAGE CODE
Language code of text/sound track or separate title English
042 ## - AUTHENTICATION CODE
Authentication code dc
072 #7 - SUBJECT CATEGORY CODE
Subject category code M
Source bicssc
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Pereira, Maria Carmo
Relator code edt
9 (RLIN) 1598032
245 10 - TITLE STATEMENT
Title PLGA Based Drug Carrier and Pharmaceutical Applications
260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT)
Place of publication, distribution, etc Basel, Switzerland
Name of publisher, distributor, etc MDPI - Multidisciplinary Digital Publishing Institute
Date of publication, distribution, etc 2021
300 ## - PHYSICAL DESCRIPTION
Extent 1 electronic resource (328 p.)
506 0# - RESTRICTIONS ON ACCESS NOTE
Terms governing access Open Access
Source of term star
Standardized terminology for access restriction Unrestricted online access
520 ## - SUMMARY, ETC.
Summary, etc Poly(lactic-co-glycolic acid) (PLGA) is one of the most successful polymers used for producing therapeutic devices, such as drug carriers (DC). PLGA is one of the few polymers that the Food and Drug Administration (FDA) has approved for human administration due to its biocompatibility and biodegradability. In recent years, DC produced with PLGA has gained enormous attention for its versatility in transporting different type of drugs, e.g., hydrophilic or hydrophobic small molecules, or macromolecules with a controlled drug release without modifying the physiochemical properties of the drugs. These drug delivery systems have the possibility/potential to modify their surface properties with functional groups, peptides, or other coatings to improve the interactions with biological materials. Furthermore, they present the possibility to be conjugated with specific target molecules to reach specific tissues or cells. They are also used for different therapeutic applications, such as in vaccinations, cancer treatment, neurological disorder treatment, and as anti-inflammatory agents. This book aims to focus on the recent progress of PLGA as a drug carrier and their new pharmaceutical applications.
540 ## - TERMS GOVERNING USE AND REPRODUCTION NOTE
Terms governing use and reproduction Creative Commons
-- https://creativecommons.org/licenses/by/4.0/
-- cc
-- https://creativecommons.org/licenses/by/4.0/
546 ## - LANGUAGE NOTE
Language note English
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Medicine
Source of heading or term bicssc
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term PLGA
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term nanoscaled drug delivery
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term LED
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term cancer
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term serum stability
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term reactive oxygen species
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term cellular uptake
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term terahertz spectroscopy
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term microspheres
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term drug delivery
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term formulation development
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term molecular mobility
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term vitamin E
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term tocopherol
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term PLA
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term core-shell nanoparticles
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term controlled drug release
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term BMP-2
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term PLGA nanoparticles
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term Pluronic F68
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term oxaliplatin
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term hydrogel
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term intra-abdominal anti-adhesion barrier
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term colorectal cancer
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term experimental design
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term fractional factorial design
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term O6-methylguanine DNA methyltransferase (MGMT) protein
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term glioblastoma multiforme
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term smart nanocarriers
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term folic acid
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term verteporfin
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term cisplatin
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term SKOV-3 cells
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term CHO-K1 cells
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term electroporation
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term theranostic cargo
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term double emulsion approach
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term NSAIDs
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term polymeric film
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term topical drug delivery
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term trolamine salicylate
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term triamcinolone acetonide
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term microcrystal
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term PLGA microsphere
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term local delivery
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term spray-drying technique
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term intra-articular injection
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term joint retention
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term systemic exposure
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term gadolinium
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term drug release
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term polymeric nanocarrier
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term sorafenib
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term theranostic nanoparticles
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term PLGA-PEG
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term nanoparticles
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term platelet
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term activation
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term aggregation
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term binding
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term uptake
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term tissue engineering
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term Huntington's disease
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term siRNA
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term microcarriers
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term mesenchymal stromal cells
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term drug delivery systems
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term microfluidics
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term microparticles
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term BMP-2-microspheres
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term hydrogel system
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term 17-βestradiol release
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term bone regeneration
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term osteoporosis
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term poly-lactide-co-glycolide
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term polylactic acid
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term alginate
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term ophthalmic drug delivery
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term dexamethasone
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term PLGA-NPs
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term nanomedicine
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term gastrointestinal tract
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term paclitaxel
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term in vivo imaging
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term controlled release
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term risperidone
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term microcapsules
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term oleogels
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term electron microscopy
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term three-dimensional X-ray imaging
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term nano-CT
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term biodegradable polymers
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term hydroxy-stearic acid
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term PLGA nanocapsules
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term magnetic resonance imaging
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term photoluminescence
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term magnetic targeting
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term multimodal imaging
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term theranostics
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term silicon
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term microsphere
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term n/a
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Loureiro, Joana
Relator code edt
9 (RLIN) 1598033
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Pereira, Maria Carmo
Relator code oth
9 (RLIN) 1598032
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Loureiro, Joana
Relator code oth
9 (RLIN) 1598033
856 40 - ELECTRONIC LOCATION AND ACCESS
Host name www.oapen.org
Uniform Resource Identifier <a href="https://mdpi.com/books/pdfview/book/3432">https://mdpi.com/books/pdfview/book/3432</a>
-- 0
Public note DOAB: download the publication
856 40 - ELECTRONIC LOCATION AND ACCESS
Host name www.oapen.org
Uniform Resource Identifier <a href="https://directory.doabooks.org/handle/20.500.12854/68416">https://directory.doabooks.org/handle/20.500.12854/68416</a>
-- 0
Public note DOAB: description of the publication
Holdings
Withdrawn status Lost status Damaged status Not for loan Collection code Home library Current library Date acquired Total Checkouts Date last seen Price effective from Koha item type
        E-Books Open Access OPJGU Sonepat- Campus OPJGU Sonepat- Campus 14/07/2022   14/07/2022 14/07/2022 Electronic-Books

O.P. Jindal Global University, Sonepat-Narela Road, Sonepat, Haryana (India) - 131001

Send your feedback to glus@jgu.edu.in

Hosted, Implemented & Customized by: BestBookBuddies   |   Maintained by: Global Library